Publications
- The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells2015 | Faculty of Science, Second Faculty of Medicine
- Valproic acid overcomes hypoxia-induced resistance to apoptosis2012 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Neuroblastoma stem cells - mechanisms of chemoresistance and histonedeacetylase inhibitors2012 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment2012 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells2012 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Valproic acid overcomes hypoxia-induced resistance to apoptosis2012 | Second Faculty of Medicine
- Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells2012 | Second Faculty of Medicine
- Neuroblastoma stem cells - mechanisms of chemoresistance and histonedeacetylase inhibitors2012 | Second Faculty of Medicine
- The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment2012 | Second Faculty of Medicine
- Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma2011 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
Loading network view...